Laura Lee Adams - 18 Oct 2023 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Role
Director
Signature
/s/ John Sprague, Attorney-in-fact
Issuer symbol
TTOO
Transactions as of
18 Oct 2023
Net transactions value
$0
Form type
4
Filing time
20 Oct 2023, 16:16:38 UTC
Previous filing
11 Oct 2023
Next filing
02 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTOO Common Stock Options Exercise +7 +23% 37 18 Oct 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTOO Restricted Stock Units Options Exercise $0 -7 -50% $0.000000 7 18 Oct 2023 Common Stock 7 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 On October 18, 2021 the reporting person was granted 21 RSU's that vest in three equal annual installments commencing on October 18, 2022.